Literature DB >> 26536571

Andrographolide Attenuates LPS-Induced Cardiac Malfunctions Through Inhibition of IκB Phosphorylation and Apoptosis in Mice.

Jinlong Zhang, Didi Zhu, Yulin Wang, Yunfeng Ju.   

Abstract

BACKGROUND/AIMS: Cardiac malfunction is a common complication in sepsis and significantly increases the mortality of patients in septic shock. However, no studies have examined whether andrographolide (And) reduces LPS-induced myocardial malfunction.
METHODS: Left ventricular systolic and diastolic functions were examined using echocardiography. TNF-α and IL-1β protein levels were detected by an enzyme-linked immunosorbent assay (ELISA). NO oxidation products were determined using Griess reagent. Protein expression levels of inhibitors of NF-κBα (IκB) and phospho-IκB were determined via Western blot. Oxidative injury was determined by measuring myocardial lipid peroxidation and superoxide dismutase activity. Cardiac apoptosis was examined by terminal deoxynucleotidyl transferase-mediated dUTP nickend-labeling (TUNEL) and cardiac caspase 3/7 activity.
RESULTS: And blunted LPS-induced myocardial malfunctions in mice. LPS induced TNF-α, IL-1β, and NO production as well as I-κB phosphorylation. Cardiac apoptosis was attenuated via incubation with And, but the extent of oxidative injury remained unaffected.
CONCLUSION: And prevents LPS-induced cardiac malfunctions in mice by inhibiting TNF-α, IL-1β, and NO production, IκB phosphorylation, and cardiac apoptosis, indicating that And may be a potential agent for preventing myocardial malfunction during sepsis.
© 2015 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26536571     DOI: 10.1159/000438528

Source DB:  PubMed          Journal:  Cell Physiol Biochem        ISSN: 1015-8987


  9 in total

1.  Andrographolide and Its Derivative Potassium Dehydrographolide Succinate Suppress PRRSV Replication in Primary and Established Cells via Differential Mechanisms of Action.

Authors:  Lizhan Su; Yarou Gao; Mingxin Zhang; Zexin Liu; Qisheng Lin; Lang Gong; Jianying Guo; Lixia Chen; Tongqing An; Jianxin Chen
Journal:  Virol Sin       Date:  2021-10-27       Impact factor: 4.327

2.  Andrographolide attenuates viral myocarditis through interactions with the IL-10/STAT3 and P13K/AKT/NF-κβ signaling pathways.

Authors:  Yaxin Zhao; Meng Wang; Yang Li; Wanting Dong
Journal:  Exp Ther Med       Date:  2018-06-29       Impact factor: 2.447

3.  Andrographolide Protects against Aortic Banding-Induced Experimental Cardiac Hypertrophy by Inhibiting MAPKs Signaling.

Authors:  Qing Q Wu; Jian Ni; Ning Zhang; Hai H Liao; Qi Z Tang; Wei Deng
Journal:  Front Pharmacol       Date:  2017-11-14       Impact factor: 5.810

4.  Thyroxine Affects Lipopolysaccharide-Induced Macrophage Differentiation and Myocardial Cell Apoptosis via the NF-κB p65 Pathway Both In Vitro and In Vivo.

Authors:  Shan Zhu; Yuan Wang; Hongtao Liu; Wen Wei; Yi Tu; Chuang Chen; Junlong Song; Zhiliang Xu; Juanjuan Li; Changhua Wang; Shengrong Sun
Journal:  Mediators Inflamm       Date:  2019-05-14       Impact factor: 4.711

5.  Beneficial effects of andrographolide in a rat model of autoimmune myocarditis and its effects on PI3K/Akt pathway.

Authors:  Qi Zhang; Li-Qun Hu; Hong-Qi Li; Jun Wu; Na-Na Bian; Guang Yan
Journal:  Korean J Physiol Pharmacol       Date:  2019-02-15       Impact factor: 2.016

Review 6.  A review on the molecular basis underlying the protective effects of Andrographis paniculata and andrographolide against myocardial injury.

Authors:  Sok Kuan Wong; Kok-Yong Chin; Soelaiman Ima-Nirwana
Journal:  Drug Des Devel Ther       Date:  2021-11-10       Impact factor: 4.162

7.  Andrographolide inhibits arrhythmias and is cardioprotective in rabbits.

Authors:  Mengliu Zeng; Wanzhen Jiang; Youjia Tian; Jie Hao; Zhenzhen Cao; Zhipei Liu; Chen Fu; Peihua Zhang; Jihua Ma
Journal:  Oncotarget       Date:  2017-05-22

8.  Andrographolide mitigates IL‑1β‑induced human nucleus pulposus cells degeneration through the TLR4/MyD88/NF‑κB signaling pathway.

Authors:  Lilian Zhang; Qi Chen; Haoli Wang; Jian Yang; Sunren Sheng
Journal:  Mol Med Rep       Date:  2018-10-25       Impact factor: 2.952

9.  Andrographolide Protects Against Adverse Cardiac Remodeling After Myocardial Infarction through Enhancing Nrf2 Signaling Pathway.

Authors:  Saiyang Xie; Wei Deng; Jiaojiao Chen; Qing-Qing Wu; Hongjian Li; Juan Wang; Li Wei; Chen Liu; Mingxia Duan; Zhulan Cai; Qingwen Xie; Tongtong Hu; Xiaofeng Zeng; Qizhu Tang
Journal:  Int J Biol Sci       Date:  2020-01-01       Impact factor: 6.580

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.